Tracy Li

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. doi Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population
    Tracy Li
    Bristol Myers Squibb, Princeton, New Jersey 08543, USA
    Arthritis Rheum 61:755-63. 2009
  2. doi Validation of a simple activity participation measure for rheumatoid arthritis clinical trials
    T Li
    Global Health Outcomes, P O Box 4000, Mail stop J23 02, Bristol Myers Squibb, Princeton, NJ 08543, USA
    Rheumatology (Oxford) 48:170-5. 2009
  3. ncbi Decreased external home help use with improved clinical status in rheumatoid arthritis: an exploratory analysis of the Abatacept in Inadequate responders to Methotrexate (AIM) trial
    Tracy Li
    Global Epidemiology and Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey, USA
    Clin Ther 30:734-48. 2008
  4. doi Improvements in participation in usual daily activities in patients with rheumatoid arthritis treated with abatacept
    Tracy Li
    Global Health Outcomes, Bristol Myers Squibb, Princeton, NJ 08543, USA
    Value Health 14:361-70. 2011
  5. ncbi The multi-faceted assessment of independence in patients with rheumatoid arthritis: preliminary validation from the ATTAIN study
    Afton L Hassett
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08903 0019, USA
    Curr Med Res Opin 24:1443-53. 2008
  6. doi Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
    Joel M Kremer
    Center for Rheumatology, Albany Medical College, Albany, New York 12206, USA
    Arthritis Rheum 58:953-63. 2008
  7. ncbi Item response theory methods can improve the measurement of physical function by combining the modified health assessment questionnaire and the SF-36 physical function scale
    Marie Martin
    QualityMetric Incorporated, 640 George Washington Highway, Suite 201, Lincoln, 02865, RI, USA
    Qual Life Res 16:647-60. 2007
  8. pmc Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
    Michael Weinblatt
    Rheumatology and Immunology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Ann Rheum Dis 66:228-34. 2007
  9. ncbi Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial
    Joel M Kremer
    Center for Rheumatology, Albany, New York, USA
    Ann Intern Med 144:865-76. 2006
  10. ncbi Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life
    Paul Emery
    Rheumatology and Rehabilitation Research Unit, University of Leeds, UK
    J Rheumatol 33:681-9. 2006

Detail Information

Publications14

  1. doi Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population
    Tracy Li
    Bristol Myers Squibb, Princeton, New Jersey 08543, USA
    Arthritis Rheum 61:755-63. 2009
    ..To estimate the long-term direct medical costs and health care utilization for patients with systemic lupus erythematosus (SLE) and a subset of SLE patients with nephritis...
  2. doi Validation of a simple activity participation measure for rheumatoid arthritis clinical trials
    T Li
    Global Health Outcomes, P O Box 4000, Mail stop J23 02, Bristol Myers Squibb, Princeton, NJ 08543, USA
    Rheumatology (Oxford) 48:170-5. 2009
    ..To examine the validity, reliability and sensitivity to change of the Activity Participation Questionnaire (APaQ), a simple measure of activity participation for patients with RA...
  3. ncbi Decreased external home help use with improved clinical status in rheumatoid arthritis: an exploratory analysis of the Abatacept in Inadequate responders to Methotrexate (AIM) trial
    Tracy Li
    Global Epidemiology and Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey, USA
    Clin Ther 30:734-48. 2008
    ....
  4. doi Improvements in participation in usual daily activities in patients with rheumatoid arthritis treated with abatacept
    Tracy Li
    Global Health Outcomes, Bristol Myers Squibb, Princeton, NJ 08543, USA
    Value Health 14:361-70. 2011
    ..To examine changes in activity participation following abatacept treatment for rheumatoid arthritis (RA), and which factors contributed to such changes...
  5. ncbi The multi-faceted assessment of independence in patients with rheumatoid arthritis: preliminary validation from the ATTAIN study
    Afton L Hassett
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08903 0019, USA
    Curr Med Res Opin 24:1443-53. 2008
    ..To consider the feasibility of assessing multiple facets of independence in rheumatoid arthritis (RA) using a measure developed from existing items and examining its face validity, construct validity and responsiveness to change...
  6. doi Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
    Joel M Kremer
    Center for Rheumatology, Albany Medical College, Albany, New York 12206, USA
    Arthritis Rheum 58:953-63. 2008
    ..To evaluate the efficacy, radiographic changes, and safety of abatacept and methotrexate therapy through 2 years in a long-term extension of a previously published 1-year study...
  7. ncbi Item response theory methods can improve the measurement of physical function by combining the modified health assessment questionnaire and the SF-36 physical function scale
    Marie Martin
    QualityMetric Incorporated, 640 George Washington Highway, Suite 201, Lincoln, 02865, RI, USA
    Qual Life Res 16:647-60. 2007
    ....
  8. pmc Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
    Michael Weinblatt
    Rheumatology and Immunology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    Ann Rheum Dis 66:228-34. 2007
    ....
  9. ncbi Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial
    Joel M Kremer
    Center for Rheumatology, Albany, New York, USA
    Ann Intern Med 144:865-76. 2006
    ..The selective co-stimulation modulator abatacept demonstrated efficacy for treating rheumatoid arthritis in early clinical studies...
  10. ncbi Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life
    Paul Emery
    Rheumatology and Rehabilitation Research Unit, University of Leeds, UK
    J Rheumatol 33:681-9. 2006
    ..This study examined the effect of abatacept, a costimulation modulator, on the health-related quality of life (HRQOL) of patients with rheumatoid arthritis (RA)...
  11. ncbi Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition
    Mark C Genovese
    Stanford University Medical Center, Stanford, Calif, USA
    N Engl J Med 353:1114-23. 2005
    ....
  12. ncbi Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial
    Joel M Kremer
    Center for Rheumatology, Albany, NY 12206, USA
    Arthritis Rheum 52:2263-71. 2005
    ..To determine the clinical efficacy, safety, and immunogenicity of abatacept (CTLA-4Ig), a selective costimulation modulator, in patients with rheumatoid arthritis (RA) that has remained active despite methotrexate (MTX) therapy...
  13. ncbi Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis
    George Wells
    Department of Epidemiology and Community Medicine, University of Ottawa, Ontario, Canada
    J Rheumatol 34:280-9. 2007
    ....
  14. ncbi Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales
    Frederick Wolfe
    National Data Bank for Rheumatic Diseases, University of Kansas School of Medicine, Wichita, Kansas 67214, USA
    J Rheumatol 33:1942-51. 2006
    ..SD has taken on new importance with the observation that etanercept and infliximab reduce daytime sleepiness, and patient groups indicate that sleep is an important issue...